<DOC>
	<DOC>NCT02657980</DOC>
	<brief_summary>Study Type: Interventional Study Design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment</brief_summary>
	<brief_title>The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder</brief_title>
	<detailed_description>Patients will be randomized to receive either real or sham-tDCS as well as anti-depressant drugs. tDCS will be applied over the left (anode) and right (cathode) dorsolateral prefrontal cortex (DLPFC). Patients will visit the hospital to get tDCS administrations 5 days a week for 2 weeks. They will be evaluated every 2 weeks.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>Has a diagnosis of a major depressive disorder as confirmed by the SCIDIV and MINI (without psychotic features) Greater than 22 points of MontgomeryAsberg Depression Rating Scale Aged 19 to 65. Has provided informed consent Has other mental disorders diagnosed by AxisI, except major depressive disorder (However, subject who is diagnosed as both major depressive disorder as well as anxiety disorder can participate the study.) History of suicidal attempt in the last 6 months Diagnosed with bipolar or psychotic major depressive disorder Diagnosed with other depressive disorders: dysthymic disorder, and depressive disorders that are not elsewhere classified. Has hypersensitivity to sertraline ingredients A score of 5 or greater for the question #10 in MADRS Diagnosed with closed angle glaucoma or has a history of glaucoma. History of participation in other clinical trials within 30days. A major and/or unstable medical or neurologic illness Currently taking substances that contain sertraline, mono amine oxidase inhibitor, or pimozide Pregnant or has a positive pregnancy serum test.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>tDCS</keyword>
	<keyword>MDD</keyword>
	<keyword>transcranial Direct Current Stimulation</keyword>
</DOC>